Discontinuation report TEVA-VENLAFAXINE XR

Last updated on 2020-06-11 History
Report ID 117546
Drug Identification Number 02275023
Brand name TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR 37.5MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 37.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2020-06-08
Remaining supply date 2020-06-08
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transitioned TEVA product to ACT-VENLAFAXINE.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-06-11 French Compare
v1 2020-06-11 English Compare